Alexander Breskin

13PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 07, 2026
A mortality model for relapsed or refractory multiple myeloma: emulation of subjective life expectancy criteria from a clinical trial in real-world data.

|Jun 12, 2026
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.

|Apr 01, 2026
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

Shaji Kumar, Katja C Weisel, Paul Spin

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

|Jun 27, 2025
Background rates of medical events of interest before and during the COVID-19 pandemic: a longitudinal cohort study using claims data.

Victor O Popoola, Daniel Keebler, Michelle Skornicki

|Sep 01, 2024
Bridged treatment comparisons: an illustrative application in HIV treatment.

Paul N Zivich, Stephen R Cole, Jessie K Edwards

Pageof 3

Frequent Collaborators

4 joint publications

Christian Hampp

4 joint publications

Glenn S Kroog

3 joint publications

Mostafa Shokoohi

3 joint publications

Jessie K Edwards